Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-977-3 | CAS number: 7783-06-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- disregarded due to major methodological deficiencies
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- There are a number of problems with this study. For example, a 75 to 100% incidence of pneumonia was reported in the vehicle control and treated groups, however, a 0% incidence of pneumonia was reported for the non gavaged, rack control group. This information indicates procedural problems with the dosing of the animals. Also, there was one group where mortality was 50%, the high dose male group. However, the cause of death was not determined. In addition, a malady diagnosed as ulcerative dermatitis was common across all groups. Good Laboratory Practice would preclude the acceptance of data from such diseased animals for drawing conclusions regarding the effects of H2S.
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Reference Type:
- secondary source
- Title:
- TOXICOLOGICAL REVIEW OF HYDROGEN SULFIDE (CAS No. 7783-06-4). In Support of Summary Information on the Integrated Risk Information System (IRIS)
- Author:
- U.S. Environmental Protection Agency
- Year:
- 2 003
- Bibliographic source:
- EPA/635/R-03/005. www.epa.gov/iris
Materials and methods
Test material
- Reference substance name:
- Hydrogen sulphide
- EC Number:
- 231-977-3
- EC Name:
- Hydrogen sulphide
- Cas Number:
- 7783-06-4
- Molecular formula:
- H2S
- IUPAC Name:
- hydrogen sulfide
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
Doses / concentrations
- Remarks:
- Doses / Concentrations:
1, 3.5, or 7 mg/kg/day
Basis:
actual ingested
- Control animals:
- yes, concurrent vehicle
Results and discussion
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Executive summary:
Male and female Sprague-Dawley rats (20/sex/dose group) were administered 0, 1, 3.5, or 7 mg/kg-day H2S by gavage daily for 89 days. Dose-levels were determined after a 14-day range-finding study. Hydrogen sulfide doses were prepared by purging deoxygenated deionized water with pure H2S gas. Prepared H2S solutions were stored in amber vials with Teflon seals and fresh vials were used at each dose administration. Dosing solutions were prepared weekly and solution stability was determined. Animals were examined for mortality at the beginning and end of each working day, and clinical signs were monitored immediately after dose administration. Food consumption of 10 rats per dose group was determined weekly. Animals were weighed weekly during the treatment period and at necropsy. Blood samples were collected from the suborbital sinus of animals prior to study initiation, days 27 to 31 of treatment, and before necropsy. Blood and platelet counts were determined, and clinical chemistry was performed. At study termination, animals were sacrificed by carbon dioxide asphyxiation. Sacrificed animals and animals that died during the treatment period were subjected to a full necropsy. In control and high-dose animals, liver, kidney, spleen, gonad, 19 -20-brain, heart, adrenal, and gross lesions were examined microscopically. In the low- and mid-dose groups, only lung, kidney, liver, and gross lesions were examined microscopically. Mortality was 50% in the high-dose males compared to 5% in control males. No deaths were observed in high-dose females. Mortality in mid-dose males and females was 10 and 5%, respectively, and no deaths were observed in low-dose animals or control females.
Compound-related neuromuscular and behavioral signs were observed in high-dose male and female animals, with the males displaying a higher incidence of these effects (Anderson, 1987). High dose-males exhibited abnormal posture, convulsions, fist clutching, sedation, unusual vocalization, piloerection, labored breathing, and increased respiratory rates. High-dose females exhibited convulsion, sedation, and labored respiration. Although restlessness was observed in all treated males, and increased salivation in all treated females, these clinical signs generally occurred sporadically, and the incidence of these findings did not show a clear dose-response. Therefore, the toxicological significance of restlessness in treated males, and salivation in treated females, is not clear. No significant differences in body weights were noted in any of the treated animals. In addition, no differences in food consumption were noted between treated and control groups. There were no treatment-related effects in hematology or clinical chemistry.
Ophthalmological findings prior to sacrifice were normal. The most common findings at necropsy were pink and red mottled lungs, which occurred in all groups. In high-dose males that died prior to sacrifice, pink-red discoloration of the lungs, nasal discharge, penile discharge, reddening of the scrotal sac, and darkening of the spleen were noted. Although absolute organ weights were not affected by treatment, relative heart weights increased (p< in high-dose males, and relative kidney weights increased (p< 0.05) in high-dose females. No gross lesions could be attributed to compound administration and all microscopic findings were considered incidental to compound administration.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.